Company intelligence / Profile preview

BioLegend

San Diego, California, United Statesbiolegend.com ↗

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

BioLegend develops and manufactures over 17,000 high-quality antibodies and reagents supporting biomedical research in immunology, neuroscience, cancer biology and stem cells. The company has pioneered innovative technologies such as Brilliant Violet™ fluorophores for flow cytometry and TotalSeq™ antibody–oligonucleotide conjugates for single-cell proteogenomics. Its products are widely cited in scientific literature (>25k citations). In July 2021 it was acquired by PerkinElmer (now Revvity) for $5.25 billion but continues to operate under the BioLegend brand within Revvity’s life science portfolio[1][7].

Modalities: AntibodyMonoclonal antibodyPolyclonal antibodyRecombinant proteinBead-based multiplex assayMagnetic bead-based cell separation systemAntibody-drug conjugate (for research use)Oligonucleotide-antibody conjugate (TotalSeq™)ELISA kit/reagent platform products
Industry: Non-Drug Biotech

Partnerships

Parker Institute for Cancer ImmunotherapyTomy Digital Biology Co., Ltd.Sirigen Group Ltd.

Beyond the preview

Go deeper on BioLegend.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioLegend.

Explore the full profile